{
    "nctId": "NCT01699867",
    "briefTitle": "Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)",
    "officialTitle": "Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Patients With All Positive Margins Correctly Identified With the Device",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women 18 years of age or older\n2. Signed informed consent form\n3. Women who have been histologically diagnosed with carcinoma of the breast prior to surgery\n4. Patients planning breast preservation and undergoing lumpectomy (partial mastectomy) procedure\n\nExclusion Criteria:\n\n1. Multicentric disease (histologically diagnosed cancer in two different quadrants of the breast)\n2. Neoadjuvant systemic therapy\n3. All T4 tumors\n4. Previous radiation in the operated breast\n5. Prior surgical procedure in the same quadrant\n6. Implants in the operated breast\n7. Pregnancy\n8. Lactation\n9. Participating in any other investigational study for either drug or device which can influence collection of valid data under this study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}